These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

868 related articles for article (PubMed ID: 31350260)

  • 1. Disruption of GpI mGluR-Dependent Cav2.3 Translation in a Mouse Model of Fragile X Syndrome.
    Gray EE; Murphy JG; Liu Y; Trang I; Tabor GT; Lin L; Hoffman DA
    J Neurosci; 2019 Sep; 39(38):7453-7464. PubMed ID: 31350260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired activity-dependent FMRP translation and enhanced mGluR-dependent LTD in Fragile X premutation mice.
    Iliff AJ; Renoux AJ; Krans A; Usdin K; Sutton MA; Todd PK
    Hum Mol Genet; 2013 Mar; 22(6):1180-92. PubMed ID: 23250915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voltage-Independent SK-Channel Dysfunction Causes Neuronal Hyperexcitability in the Hippocampus of
    Deng PY; Carlin D; Oh YM; Myrick LK; Warren ST; Cavalli V; Klyachko VA
    J Neurosci; 2019 Jan; 39(1):28-43. PubMed ID: 30389838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fragile X mental retardation protein regulates protein expression and mRNA translation of the potassium channel Kv4.2.
    Gross C; Yao X; Pong DL; Jeromin A; Bassell GJ
    J Neurosci; 2011 Apr; 31(15):5693-8. PubMed ID: 21490210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a fragile X mental retardation protein-mediated translational switch in metabotropic glutamate receptor-triggered Arc translation and long-term depression.
    Niere F; Wilkerson JR; Huber KM
    J Neurosci; 2012 Apr; 32(17):5924-36. PubMed ID: 22539853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabotropic receptor-dependent long-term depression persists in the absence of protein synthesis in the mouse model of fragile X syndrome.
    Nosyreva ED; Huber KM
    J Neurophysiol; 2006 May; 95(5):3291-5. PubMed ID: 16452252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulated metabotropic glutamate receptor-dependent translation of AMPA receptor and postsynaptic density-95 mRNAs at synapses in a mouse model of fragile X syndrome.
    Muddashetty RS; Kelić S; Gross C; Xu M; Bassell GJ
    J Neurosci; 2007 May; 27(20):5338-48. PubMed ID: 17507556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragile X Mental Retardation Protein (FMRP) controls diacylglycerol kinase activity in neurons.
    Tabet R; Moutin E; Becker JA; Heintz D; Fouillen L; Flatter E; Krężel W; Alunni V; Koebel P; Dembélé D; Tassone F; Bardoni B; Mandel JL; Vitale N; Muller D; Le Merrer J; Moine H
    Proc Natl Acad Sci U S A; 2016 Jun; 113(26):E3619-28. PubMed ID: 27233938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic upregulation of BK channel activity normalizes multiple synaptic and circuit defects in a mouse model of fragile X syndrome.
    Deng PY; Klyachko VA
    J Physiol; 2016 Jan; 594(1):83-97. PubMed ID: 26427907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astroglial FMRP-dependent translational down-regulation of mGluR5 underlies glutamate transporter GLT1 dysregulation in the fragile X mouse.
    Higashimori H; Morel L; Huth J; Lindemann L; Dulla C; Taylor A; Freeman M; Yang Y
    Hum Mol Genet; 2013 May; 22(10):2041-54. PubMed ID: 23396537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective Deletion of Astroglial FMRP Dysregulates Glutamate Transporter GLT1 and Contributes to Fragile X Syndrome Phenotypes In Vivo.
    Higashimori H; Schin CS; Chiang MS; Morel L; Shoneye TA; Nelson DL; Yang Y
    J Neurosci; 2016 Jul; 36(27):7079-94. PubMed ID: 27383586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Jun N-terminal kinase regulates mGluR-dependent expression of post-synaptic FMRP target proteins.
    Schmit TL; Dowell JA; Maes ME; Wilhelm M
    J Neurochem; 2013 Dec; 127(6):772-81. PubMed ID: 24047560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The fragile X mental retardation protein and group I metabotropic glutamate receptors regulate levels of mRNA granules in brain.
    Aschrafi A; Cunningham BA; Edelman GM; Vanderklish PW
    Proc Natl Acad Sci U S A; 2005 Feb; 102(6):2180-5. PubMed ID: 15684045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fragile X-like behaviors and abnormal cortical dendritic spines in cytoplasmic FMR1-interacting protein 2-mutant mice.
    Han K; Chen H; Gennarino VA; Richman R; Lu HC; Zoghbi HY
    Hum Mol Genet; 2015 Apr; 24(7):1813-23. PubMed ID: 25432536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabotropic glutamate receptor activation regulates fragile x mental retardation protein and FMR1 mRNA localization differentially in dendrites and at synapses.
    Antar LN; Afroz R; Dictenberg JB; Carroll RC; Bassell GJ
    J Neurosci; 2004 Mar; 24(11):2648-55. PubMed ID: 15028757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabotropic glutamate receptors and fragile x mental retardation protein: partners in translational regulation at the synapse.
    Ronesi JA; Huber KM
    Sci Signal; 2008 Feb; 1(5):pe6. PubMed ID: 18272470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S6K1 phosphorylates and regulates fragile X mental retardation protein (FMRP) with the neuronal protein synthesis-dependent mammalian target of rapamycin (mTOR) signaling cascade.
    Narayanan U; Nalavadi V; Nakamoto M; Thomas G; Ceman S; Bassell GJ; Warren ST
    J Biol Chem; 2008 Jul; 283(27):18478-82. PubMed ID: 18474609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of the fragile X mental retardation protein decouples metabotropic glutamate receptor dependent priming of long-term potentiation from protein synthesis.
    Auerbach BD; Bear MF
    J Neurophysiol; 2010 Aug; 104(2):1047-51. PubMed ID: 20554840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fragile X mental retardation protein is required for type-I metabotropic glutamate receptor-dependent translation of PSD-95.
    Todd PK; Mack KJ; Malter JS
    Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14374-8. PubMed ID: 14614133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ICAM5 as a Novel Target for Treating Cognitive Impairment in Fragile X Syndrome.
    Pei YP; Wang YY; Liu D; Lei HY; Yang ZH; Zhang ZW; Han M; Cheng K; Chen YS; Li JQ; Cheng GR; Xu L; Wu QM; McClintock SM; Yang Y; Zhang Y; Zeng Y
    J Neurosci; 2020 Feb; 40(6):1355-1365. PubMed ID: 31882402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.